CSPC Pharmaceutical starts Phase I trial of SYH2092 injection
CSPC Pharmaceutical has initiated a Phase I clinical trial of SYH2092 injection.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.